Takeda Pharmaceutical Co., Ltd. et al v. TWi Pharmaceuticals, Inc.
Filing
167
CASE MANAGEMENT ORDER. Signed by Judge Lucy H. Koh on 4/9/2015. (lhklc3S, COURT STAFF) (Filed on 4/9/2015)
1
2
3
4
5
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN JOSE DIVISION
6
7
9
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,
10
Plaintiffs,
United States District Court
For the Northern District of California
8
11
12
v.
TWI PHARMACEUTICALS, INC.,
Defendant.
13
)
)
)
)
)
)
)
)
)
)
)
)
)
Case No.: 13-CV-02420-LHK
CASE MANAGEMENT ORDER
14
15
Plaintiffs’ Attorneys: Jeffrey Weinberger; Ted Dane; Heather Takahashi; John Schwab
Defendant’s Attorneys: Don J. Mizerk; John Sholar
16
A case management conference was held on April 9, 2015.
17
18
19
Each side is limited to four (4) motions in limine. Each motion and opposition shall not
exceed five (5) pages in length. The parties may not file replies.
The parties stipulated to shorten the length of trial to five (5) days. Accordingly, the case
schedule is as follows:
20
Scheduled Event
Date
22
Deadline for Takeda to File and Serve a Narrowed List of
Asserted Claims
April 16, 2015
(max 5 claims)
23
Final Pretrial Conference
May 14, 2015, at 1:30 p.m.
Bench Trial
June 2, 2015, at 9:00 a.m.
Length of Trial
5 days
21
24
25
26
27
IT IS SO ORDERED.
Dated: April 9, 2015
_________________________________
LUCY H. KOH
United States District Judge
28
1
Case Nos.: 13-CV-02420-LHK
CASE MANAGEMENT ORDER
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?